1h Free Analyst Time
SummarySpeak directly to the analyst to clarify any post sales queries you may have.
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Pipeline Review, H2 2020, provides an overview of the Malaria (Infectious Disease) pipeline landscape.
Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria and pregnant women and their unborn children. Symptoms may include fever, chills, headache, sweats, fatigue, enlarged spleen, nausea and vomiting. Treatment includes anti-malarial medicines and healthy lifestyle.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Malaria - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Malaria (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Malaria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Malaria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 1, 2, 14, 16, 54, 29 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 9, 19, 40 and 34 molecules, respectively.
Malaria (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Malaria (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Malaria (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Malaria (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Malaria (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Malaria (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Malaria (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Malaria (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
IntroductionMalaria - Overview
Malaria - Therapeutics Development
Malaria - Therapeutics Assessment
Malaria - Companies Involved in Therapeutics Development
Malaria - Drug Profiles
Malaria - Dormant Projects
Malaria - Discontinued Products
Malaria - Product Development Milestones
Appendix
List of Tables
- Number of Products under Development for Malaria, H2 2020
- Number of Products under Development by Companies, H2 2020
- Number of Products under Development by Universities/Institutes, H2 2020
- Products under Development by Companies, H2 2020
- Products under Development by Universities/Institutes, H2 2020
- Number of Products by Stage and Target, H2 2020
- Number of Products by Stage and Mechanism of Action, H2 2020
- Number of Products by Stage and Route of Administration, H2 2020
- Number of Products by Stage and Molecule Type, H2 2020
- Malaria - Pipeline by 4SC AG, H2 2020
- Malaria - Pipeline by 60 Degrees Pharmaceuticals LLC, H2 2020
- Malaria - Pipeline by AbbVie Inc, H2 2020
- Malaria - Pipeline by AchilleS Vaccines Srl, H2 2020
- Malaria - Pipeline by Akshaya Bio Inc, H2 2020
- Malaria - Pipeline by Alfasigma SpA, H2 2020
- Malaria - Pipeline by AliquantumRx Inc, H2 2020
- Malaria - Pipeline by Allergy Therapeutics Plc, H2 2020
- Malaria - Pipeline by Altimmune Inc, H2 2020
- Malaria - Pipeline by Artemis Therapeutics Inc, H2 2020
- Malaria - Pipeline by Artificial Cell Technologies Inc, H2 2020
- Malaria - Pipeline by AUM LifeTech Inc, H2 2020
- Malaria - Pipeline by Avalia Immunotherapies Ltd, H2 2020
- Malaria - Pipeline by Bharat Biotech Ltd, H2 2020
- Malaria - Pipeline by Brain-Gen LLC, H2 2020
- Malaria - Pipeline by Bristol-Myers Squibb Co, H2 2020
- Malaria - Pipeline by Cadila Healthcare Ltd, H2 2020
- Malaria - Pipeline by Carna Biosciences Inc, H2 2020
- Malaria - Pipeline by Cascade Therapeutics Inc, H2 2020
- Malaria - Pipeline by Cellics Therapeutics Inc, H2 2020
- Malaria - Pipeline by Cesa Alliance SA, H2 2020
- Malaria - Pipeline by Cilian AG, H2 2020
- Malaria - Pipeline by Collaborations Pharmaceuticals Inc, H2 2020
- Malaria - Pipeline by Curevac AG, H2 2020
- Malaria - Pipeline by DesignMedix Inc, H2 2020
- Malaria - Pipeline by DMG Deutsche Malaria GmbH, H2 2020
- Malaria - Pipeline by Eisai Co Ltd, H2 2020
- Malaria - Pipeline by ElSohly Laboratories Inc, H2 2020
- Malaria - Pipeline by EpicentRx Inc, H2 2020
- Malaria - Pipeline by EpiVax Inc, H2 2020
- Malaria - Pipeline by Etna Biotech Srl, H2 2020
- Malaria - Pipeline by Evotec SE, H2 2020
- Malaria - Pipeline by Expres2ion Biotechnologies ApS, H2 2020
- Malaria - Pipeline by Fox Chase Chemical Diversity Center Inc, H2 2020
- Malaria - Dormant Projects, H2 2020
- Malaria - Discontinued Products, H2 2020
List of Figures
- Number of Products under Development for Malaria, H2 2020
- Number of Products under Development by Companies, H2 2020
- Number of Products under Development by Universities/Institutes, H2 2020
- Number of Products by Top 10 Targets, H2 2020
- Number of Products by Stage and Top 10 Targets, H2 2020
- Number of Products by Top 10 Mechanism of Actions, H2 2020
- Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
- Number of Products by Top 10 Routes of Administration, H2 2020
- Number of Products by Stage and Top 10 Routes of Administration, H2 2020
- Number of Products by Top 10 Molecule Types, H2 2020
- Number of Products by Stage and Top 10 Molecule Types, H2 2020
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4SC AG
- 60 Degrees Pharmaceuticals LLC
- AbbVie Inc
- AchilleS Vaccines Srl
- Akshaya Bio Inc
- Alfasigma SpA
- AliquantumRx Inc
- Allergy Therapeutics Plc
- Altimmune Inc
- Artemis Therapeutics Inc
- Artificial Cell Technologies Inc
- AUM LifeTech Inc
- Avalia Immunotherapies Ltd
- Bharat Biotech Ltd
- Brain-Gen LLC
- Bristol-Myers Squibb Co
- Cadila Healthcare Ltd
- Carna Biosciences Inc
- Cascade Therapeutics Inc
- Cellics Therapeutics Inc
- Cesa Alliance SA
- Cilian AG
- Collaborations Pharmaceuticals Inc
- Curevac AG
- DesignMedix Inc
- DMG Deutsche Malaria GmbH
- Eisai Co Ltd
- ElSohly Laboratories Inc
- EpicentRx Inc
- EpiVax Inc
- Etna Biotech Srl
- Evotec SE
- Expres2ion Biotechnologies ApS
- Fox Chase Chemical Diversity Center Inc
- GeoVax Labs Inc
- GlaxoSmithKline Plc
- Hawaii Biotech Inc
- Ichor Medical Systems Inc
- Immtech Pharmaceuticals Inc
- Immune Modulation Inc
- Imutex Ltd
- IMV Inc
- Indoco Remedies Ltd
- Innovex Therapeutics SL
- IPCA Laboratories Ltd
- Jacobus Pharmaceutical Co Inc
- Kainomyx Inc
- Kymab Ltd
- LondonPharma Ltd
- Lumen Bioscience Inc
- Lyndra Therapeutics Inc.
- MedinCell SA
- MediSynergics LLC
- MegaNano BioTech Inc
- Merck & Co Inc
- Merck KGaA
- Microbiotix Inc
- Mitsubishi Tanabe Pharma Corp
- Mycosynthetix Inc
- Mymetics Corp
- Nobelpharma Co Ltd
- Novartis AG
- Ocean Biomedical
- Osivax SAS
- Otsuka Holdings Co Ltd
- Pacific Meniuoke Biopharmaceutical Company
- Pfizer Inc
- Protein Potential LLC
- Radix Pharmaceuticals Inc
- Replikins Ltd
- Rodos BioTarget GmbH
- Sanaria Inc
- Sanofi
- Serum Institute of India Ltd
- Shanghai Fosun Pharmaceutical (Group) Co Ltd
- Shin Poong Pharm Co Ltd
- Sumaya Biotech GmbH & Co KG
- Sumitomo Dainippon Pharma Co Ltd
- Takeda Pharmaceutical Co Ltd
- Theravectys SA
- Titan Pharmaceuticals Inc
- Vac4All SAS
- VLP Biotech Inc
- VLP Therapeutics LLC
